Stocks and Investing Stocks and Investing
Tue, March 22, 2022
Mon, March 21, 2022

Swayampakula Ramakanth Initiated (BCAB) at Strong Buy and Held Target at $25 on, Mar 21st, 2022


Published on 2024-10-27 20:09:06 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Initiated "BioAtla, Inc." (BCAB) at Strong Buy and Held Target at $25 on, Mar 21st, 2022.

Swayampakula, nor any peers, have made any analyst calls on BCAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources